The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AGN-PC-00M23R     methyl7-[2-(3-acetyloxyoct-1- enyl)-5-oxo...

Synonyms: AC1L63MU, 25488-91-9
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Prostaglandin


Psychiatry related information on Prostaglandin


High impact information on Prostaglandin


Chemical compound and disease context of Prostaglandin


Biological context of Prostaglandin


Anatomical context of Prostaglandin


Associations of Prostaglandin with other chemical compounds


Gene context of Prostaglandin


Analytical, diagnostic and therapeutic context of Prostaglandin


  1. Gastric-outlet obstruction induced by prostaglandin therapy in neonates. Peled, N., Dagan, O., Babyn, P., Silver, M.M., Barker, G., Hellmann, J., Scolnik, D., Koren, G. N. Engl. J. Med. (1992) [Pubmed]
  2. Beneficial effects of prostaglandin E1 in rapidly progressive glomerulonephritis. Niwa, T., Maeda, K., Asada, H., Yamamoto, M., Yamada, K. N. Engl. J. Med. (1983) [Pubmed]
  3. Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice. Hedlund, P., Aszodi, A., Pfeifer, A., Alm, P., Hofmann, F., Ahmad, M., Fassler, R., Andersson, K.E. Proc. Natl. Acad. Sci. U.S.A. (2000) [Pubmed]
  4. Prostaglandin E receptor EP1 controls impulsive behavior under stress. Matsuoka, Y., Furuyashiki, T., Yamada, K., Nagai, T., Bito, H., Tanaka, Y., Kitaoka, S., Ushikubi, F., Nabeshima, T., Narumiya, S. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  5. Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis. Hsueh, W., Gonzalez-Crussi, F., Arroyave, J.L. Am. J. Pathol. (1986) [Pubmed]
  6. Eicosanoids in experimental and human renal disease. Stork, J.E., Rahman, M.A., Dunn, M.J. Am. J. Med. (1986) [Pubmed]
  7. Salivary prostaglandin concentrations: possible state indicators for major depression. Nishino, S., Ueno, R., Ohishi, K., Sakai, T., Hayaishi, O. The American journal of psychiatry. (1989) [Pubmed]
  8. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Brutsaert, D.L. Physiol. Rev. (2003) [Pubmed]
  9. Prostanoid receptors: structures, properties, and functions. Narumiya, S., Sugimoto, Y., Ushikubi, F. Physiol. Rev. (1999) [Pubmed]
  10. Luteolysis: a neuroendocrine-mediated event. McCracken, J.A., Custer, E.E., Lamsa, J.C. Physiol. Rev. (1999) [Pubmed]
  11. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Lazarov, O., Robinson, J., Tang, Y.P., Hairston, I.S., Korade-Mirnics, Z., Lee, V.M., Hersh, L.B., Sapolsky, R.M., Mirnics, K., Sisodia, S.S. Cell (2005) [Pubmed]
  12. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Grimm, C., Wenzel, A., Hafezi, F., Yu, S., Redmond, T.M., Remé, C.E. Nat. Genet. (2000) [Pubmed]
  13. Regulation of prostaglandin synthesis mediated by thrombin and B2 bradykinin receptors in a fibrosarcoma cell line. Becherer, P.R., Mertz, L.F., Baenziger, N.L. Cell (1982) [Pubmed]
  14. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia. Dzau, V.J., Packer, M., Lilly, L.S., Swartz, S.L., Hollenberg, N.K., Williams, G.H. N. Engl. J. Med. (1984) [Pubmed]
  15. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells. Tashjian, A.H., Voelkel, E.F., McDonough, J., Levine, L. Nature (1975) [Pubmed]
  16. Sulindac. A potentially renal-sparing nonsteroidal anti-inflammatory drug. Bunning, R.D., Barth, W.F. JAMA (1982) [Pubmed]
  17. Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VS2 carcinoma. Voelkel, E.F., Levine, L., Alper, C.A., Tashjian, A.H. J. Exp. Med. (1978) [Pubmed]
  18. Early pregnancy termination with mifepristone and misoprostol in the United States. Spitz, I.M., Bardin, C.W., Benton, L., Robbins, A. N. Engl. J. Med. (1998) [Pubmed]
  19. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. Halushka, P.V., Lurie, D., Colwell, J.A. N. Engl. J. Med. (1977) [Pubmed]
  20. Platelet-derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: role of prostaglandin production. Rozengurt, E., Stroobant, P., Waterfield, M.D., Deuel, T.F., Keehan, M. Cell (1983) [Pubmed]
  21. EGF, PGF2 alpha and insulin induce the phosphorylation of identical S6 peptides in swiss mouse 3T3 cells: effect of cAMP on early sites of phosphorylation. Martin-Pérez, J., Siegmann, M., Thomas, G. Cell (1984) [Pubmed]
  22. Role of prostaglandin-mediated vasodilatation in inflammation. Williams, T.J., Peck, M.J. Nature (1977) [Pubmed]
  23. Adherence of human peripheral blood lymphycytes to measles-infected cells. Enhancement by prostaglandin E1. Zurier, R.B., Dore-Duffy, P., Viola, M.V. N. Engl. J. Med. (1977) [Pubmed]
  24. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. Heymann, M.A., Rudolph, A.M., Silverman, N.H. N. Engl. J. Med. (1976) [Pubmed]
  25. Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model. Weiner, B.H., Ockene, I.S., Levine, P.H., Cuénoud, H.F., Fisher, M., Johnson, B.F., Daoud, A.S., Jarmolych, J., Hosmer, D., Johnson, M.H. N. Engl. J. Med. (1986) [Pubmed]
  26. Cloning and crystal structure of hematopoietic prostaglandin D synthase. Kanaoka, Y., Ago, H., Inagaki, E., Nanayama, T., Miyano, M., Kikuno, R., Fujii, Y., Eguchi, N., Toh, H., Urade, Y., Hayaishi, O. Cell (1997) [Pubmed]
  27. Prostaglandin-producing suppressor cells in Hodgkin's disease. Goodwin, J.S., Messner, R.P., Bankhurst, A.D., Peake, G.T., Saiki, J.H., Williams, R.C. N. Engl. J. Med. (1977) [Pubmed]
  28. Pharmacologic closure of patent ductus arteriosus in the premature infant. Friedman, W.F., Hirschklau, M.J., Printz, M.P., Pitlick, P.T., Kirkpatrick, S.E. N. Engl. J. Med. (1976) [Pubmed]
  29. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. Clarke, R.J., Mayo, G., Price, P., FitzGerald, G.A. N. Engl. J. Med. (1991) [Pubmed]
  30. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. Moran, M., Mozes, M.F., Maddux, M.S., Veremis, S., Bartkus, C., Ketel, B., Pollak, R., Wallemark, C., Jonasson, O. N. Engl. J. Med. (1990) [Pubmed]
  31. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. Green, T.P., Thompson, T.R., Johnson, D.E., Lock, J.E. N. Engl. J. Med. (1983) [Pubmed]
  32. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Morham, S.G., Langenbach, R., Loftin, C.D., Tiano, H.F., Vouloumanos, N., Jennette, J.C., Mahler, J.F., Kluckman, K.D., Ledford, A., Lee, C.A., Smithies, O. Cell (1995) [Pubmed]
  33. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Langenbach, R., Morham, S.G., Tiano, H.F., Loftin, C.D., Ghanayem, B.I., Chulada, P.C., Mahler, J.F., Lee, C.A., Goulding, E.H., Kluckman, K.D., Kim, H.S., Smithies, O. Cell (1995) [Pubmed]
  34. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Jones, M.K., Wang, H., Peskar, B.M., Levin, E., Itani, R.M., Sarfeh, I.J., Tarnawski, A.S. Nat. Med. (1999) [Pubmed]
  35. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., Taketo, M.M. Nat. Med. (2001) [Pubmed]
  36. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Simmons, D.L., Botting, R.M., Hla, T. Pharmacol. Rev. (2004) [Pubmed]
  37. Risk of uterine rupture during labor among women with a prior cesarean delivery. Lydon-Rochelle, M., Holt, V.L., Easterling, T.R., Martin, D.P. N. Engl. J. Med. (2001) [Pubmed]
  38. Biological activities of prostaglandin analogues and metabolites on bone in organ culture. Tashjian, A.H., Tice, J.E., Sides, K. Nature (1977) [Pubmed]
  39. Fatty acids and their prostaglandin derivatives: inhibitors of proliferation in aortic smooth muscle cells. Huttner, J.J., Gwebu, E.T., Panganamala, R.V., Milo, G.E., Cornwell, D.C., Sharma, H.M., Geer, J.C. Science (1977) [Pubmed]
  40. Renal thromboxane synthesis in excised kidney distal to renovascular lesions. Anderson, C.B., Tannenbaum, J.S., Sicard, G.A., Etheredge, E.E. JAMA (1984) [Pubmed]
  41. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. Honda, T., Segi-Nishida, E., Miyachi, Y., Narumiya, S. J. Exp. Med. (2006) [Pubmed]
WikiGenes - Universities